nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—NR3C2—dilated cardiomyopathy	0.316	1	CbGaD
Dexamethasone—NR3C2—Spironolactone—dilated cardiomyopathy	0.118	0.341	CbGbCtD
Dexamethasone—PGR—Spironolactone—dilated cardiomyopathy	0.0762	0.22	CbGbCtD
Dexamethasone—Testolactone—Spironolactone—dilated cardiomyopathy	0.0744	0.282	CrCrCtD
Dexamethasone—Fluoxymesterone—Spironolactone—dilated cardiomyopathy	0.0684	0.259	CrCrCtD
Dexamethasone—Fludrocortisone—Spironolactone—dilated cardiomyopathy	0.0666	0.253	CrCrCtD
Dexamethasone—Hydrocortisone—Spironolactone—dilated cardiomyopathy	0.0543	0.206	CrCrCtD
Dexamethasone—NR3C1—Spironolactone—dilated cardiomyopathy	0.0389	0.112	CbGbCtD
Dexamethasone—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.0335	0.0969	CbGbCtD
Dexamethasone—ABCC2—Spironolactone—dilated cardiomyopathy	0.0278	0.0803	CbGbCtD
Dexamethasone—ABCC2—Furosemide—dilated cardiomyopathy	0.019	0.0549	CbGbCtD
Dexamethasone—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0134	0.0387	CbGbCtD
Dexamethasone—ABCB1—Lisinopril—dilated cardiomyopathy	0.0103	0.0297	CbGbCtD
Dexamethasone—ABCB1—Spironolactone—dilated cardiomyopathy	0.00907	0.0262	CbGbCtD
Dexamethasone—CYP2C9—cardial valve—dilated cardiomyopathy	0.00242	0.285	CbGeAlD
Dexamethasone—Hypertrichosis—Spironolactone—dilated cardiomyopathy	0.00217	0.0585	CcSEcCtD
Dexamethasone—Glucose tolerance impaired—Furosemide—dilated cardiomyopathy	0.00166	0.045	CcSEcCtD
Dexamethasone—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.00149	0.0402	CcSEcCtD
Dexamethasone—Hypotensive—Furosemide—dilated cardiomyopathy	0.00123	0.0332	CcSEcCtD
Dexamethasone—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00108	0.0291	CcSEcCtD
Dexamethasone—Diabetic—Lisinopril—dilated cardiomyopathy	0.00101	0.0272	CcSEcCtD
Dexamethasone—Pancreatitis acute—Furosemide—dilated cardiomyopathy	0.000971	0.0262	CcSEcCtD
Dexamethasone—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.000938	0.0253	CcSEcCtD
Dexamethasone—Ulcer—Spironolactone—dilated cardiomyopathy	0.000871	0.0235	CcSEcCtD
Dexamethasone—Vasculitis—Spironolactone—dilated cardiomyopathy	0.000844	0.0228	CcSEcCtD
Dexamethasone—Blister—Furosemide—dilated cardiomyopathy	0.000622	0.0168	CcSEcCtD
Dexamethasone—Fludrocortisone—NR3C2—dilated cardiomyopathy	0.000616	0.333	CrCbGaD
Dexamethasone—Lethargy—Spironolactone—dilated cardiomyopathy	0.000611	0.0165	CcSEcCtD
Dexamethasone—Blindness—Lisinopril—dilated cardiomyopathy	0.000608	0.0164	CcSEcCtD
Dexamethasone—ANXA1—cardiac ventricle—dilated cardiomyopathy	0.000591	0.0696	CbGeAlD
Dexamethasone—ANXA1—myocardium—dilated cardiomyopathy	0.000556	0.0655	CbGeAlD
Dexamethasone—Glycosuria—Furosemide—dilated cardiomyopathy	0.000553	0.0149	CcSEcCtD
Dexamethasone—PLA2G1B—heart—dilated cardiomyopathy	0.000507	0.0598	CbGeAlD
Dexamethasone—Vasculitis—Furosemide—dilated cardiomyopathy	0.000459	0.0124	CcSEcCtD
Dexamethasone—Fluticasone Propionate—NR3C2—dilated cardiomyopathy	0.000433	0.234	CrCbGaD
Dexamethasone—Prednisolone—NR3C2—dilated cardiomyopathy	0.000405	0.219	CrCbGaD
Dexamethasone—Betamethasone—NR3C2—dilated cardiomyopathy	0.000396	0.214	CrCbGaD
Dexamethasone—ANXA1—heart—dilated cardiomyopathy	0.000388	0.0457	CbGeAlD
Dexamethasone—NR3C2—cardiac ventricle—dilated cardiomyopathy	0.000383	0.0451	CbGeAlD
Dexamethasone—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000376	0.0102	CcSEcCtD
Dexamethasone—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.000374	0.0101	CcSEcCtD
Dexamethasone—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00037	0.00999	CcSEcCtD
Dexamethasone—Alopecia—Spironolactone—dilated cardiomyopathy	0.000366	0.00988	CcSEcCtD
Dexamethasone—NR3C2—myocardium—dilated cardiomyopathy	0.00036	0.0424	CbGeAlD
Dexamethasone—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000358	0.00967	CcSEcCtD
Dexamethasone—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000345	0.00931	CcSEcCtD
Dexamethasone—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000341	0.0092	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000336	0.00908	CcSEcCtD
Dexamethasone—PGR—myocardium—dilated cardiomyopathy	0.000335	0.0394	CbGeAlD
Dexamethasone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000334	0.00903	CcSEcCtD
Dexamethasone—Lethargy—Furosemide—dilated cardiomyopathy	0.000332	0.00897	CcSEcCtD
Dexamethasone—ANXA1—cardiac atrium—dilated cardiomyopathy	0.000332	0.0391	CbGeAlD
Dexamethasone—Malaise—Spironolactone—dilated cardiomyopathy	0.000325	0.00877	CcSEcCtD
Dexamethasone—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000319	0.00862	CcSEcCtD
Dexamethasone—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000316	0.00853	CcSEcCtD
Dexamethasone—Irritability—Furosemide—dilated cardiomyopathy	0.000311	0.00839	CcSEcCtD
Dexamethasone—Discomfort—Spironolactone—dilated cardiomyopathy	0.000303	0.00818	CcSEcCtD
Dexamethasone—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000299	0.00809	CcSEcCtD
Dexamethasone—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000296	0.008	CcSEcCtD
Dexamethasone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000294	0.00794	CcSEcCtD
Dexamethasone—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000288	0.00777	CcSEcCtD
Dexamethasone—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000287	0.00775	CcSEcCtD
Dexamethasone—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.000281	0.00758	CcSEcCtD
Dexamethasone—Injury—Lisinopril—dilated cardiomyopathy	0.000266	0.00717	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000254	0.00685	CcSEcCtD
Dexamethasone—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000254	0.00685	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000252	0.00681	CcSEcCtD
Dexamethasone—NR3C2—heart—dilated cardiomyopathy	0.000251	0.0296	CbGeAlD
Dexamethasone—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000244	0.00659	CcSEcCtD
Dexamethasone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000242	0.00654	CcSEcCtD
Dexamethasone—Urticaria—Spironolactone—dilated cardiomyopathy	0.000234	0.00631	CcSEcCtD
Dexamethasone—PGR—heart—dilated cardiomyopathy	0.000234	0.0275	CbGeAlD
Dexamethasone—Irritability—Lisinopril—dilated cardiomyopathy	0.000233	0.00629	CcSEcCtD
Dexamethasone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000232	0.00628	CcSEcCtD
Dexamethasone—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000232	0.00627	CcSEcCtD
Dexamethasone—Visual impairment—Furosemide—dilated cardiomyopathy	0.000217	0.00586	CcSEcCtD
Dexamethasone—NR3C2—cardiac atrium—dilated cardiomyopathy	0.000215	0.0253	CbGeAlD
Dexamethasone—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.000212	0.0249	CbGeAlD
Dexamethasone—Eye disorder—Furosemide—dilated cardiomyopathy	0.00021	0.00568	CcSEcCtD
Dexamethasone—Pruritus—Spironolactone—dilated cardiomyopathy	0.000208	0.00562	CcSEcCtD
Dexamethasone—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000206	0.00555	CcSEcCtD
Dexamethasone—NR3C1—cardiac ventricle—dilated cardiomyopathy	0.000205	0.0242	CbGeAlD
Dexamethasone—Angiopathy—Furosemide—dilated cardiomyopathy	0.000204	0.00552	CcSEcCtD
Dexamethasone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000201	0.00543	CcSEcCtD
Dexamethasone—Arrhythmia—Furosemide—dilated cardiomyopathy	0.000201	0.00543	CcSEcCtD
Dexamethasone—CYP1B1—heart—dilated cardiomyopathy	0.000196	0.0231	CbGeAlD
Dexamethasone—Erythema—Furosemide—dilated cardiomyopathy	0.000196	0.00529	CcSEcCtD
Dexamethasone—Dizziness—Spironolactone—dilated cardiomyopathy	0.000194	0.00525	CcSEcCtD
Dexamethasone—NR3C1—myocardium—dilated cardiomyopathy	0.000193	0.0227	CbGeAlD
Dexamethasone—Weight increased—Lisinopril—dilated cardiomyopathy	0.000192	0.00519	CcSEcCtD
Dexamethasone—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000191	0.00516	CcSEcCtD
Dexamethasone—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00019	0.00514	CcSEcCtD
Dexamethasone—Vomiting—Spironolactone—dilated cardiomyopathy	0.000187	0.00505	CcSEcCtD
Dexamethasone—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000186	0.00501	CcSEcCtD
Dexamethasone—Rash—Spironolactone—dilated cardiomyopathy	0.000185	0.00501	CcSEcCtD
Dexamethasone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000185	0.005	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000184	0.00498	CcSEcCtD
Dexamethasone—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000184	0.00498	CcSEcCtD
Dexamethasone—Headache—Spironolactone—dilated cardiomyopathy	0.000184	0.00497	CcSEcCtD
Dexamethasone—Vertigo—Furosemide—dilated cardiomyopathy	0.000176	0.00476	CcSEcCtD
Dexamethasone—Nausea—Spironolactone—dilated cardiomyopathy	0.000175	0.00472	CcSEcCtD
Dexamethasone—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000172	0.00464	CcSEcCtD
Dexamethasone—Hallucination—Lisinopril—dilated cardiomyopathy	0.000168	0.00454	CcSEcCtD
Dexamethasone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00016	0.00432	CcSEcCtD
Dexamethasone—Shock—Furosemide—dilated cardiomyopathy	0.000157	0.00425	CcSEcCtD
Dexamethasone—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000157	0.00424	CcSEcCtD
Dexamethasone—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000157	0.00423	CcSEcCtD
Dexamethasone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000155	0.00418	CcSEcCtD
Dexamethasone—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000153	0.00414	CcSEcCtD
Dexamethasone—Anorexia—Furosemide—dilated cardiomyopathy	0.000152	0.00412	CcSEcCtD
Dexamethasone—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000151	0.00408	CcSEcCtD
Dexamethasone—Hypotension—Furosemide—dilated cardiomyopathy	0.000149	0.00404	CcSEcCtD
Dexamethasone—Alopecia—Lisinopril—dilated cardiomyopathy	0.000149	0.00403	CcSEcCtD
Dexamethasone—Erythema—Lisinopril—dilated cardiomyopathy	0.000147	0.00397	CcSEcCtD
Dexamethasone—ABCG2—heart—dilated cardiomyopathy	0.000146	0.0172	CbGeAlD
Dexamethasone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000144	0.00388	CcSEcCtD
Dexamethasone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000139	0.00376	CcSEcCtD
Dexamethasone—CYP1A1—heart—dilated cardiomyopathy	0.000139	0.0164	CbGeAlD
Dexamethasone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000138	0.00373	CcSEcCtD
Dexamethasone—Fatigue—Furosemide—dilated cardiomyopathy	0.000138	0.00372	CcSEcCtD
Dexamethasone—Pain—Furosemide—dilated cardiomyopathy	0.000137	0.00369	CcSEcCtD
Dexamethasone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000136	0.00368	CcSEcCtD
Dexamethasone—CYP2B6—heart—dilated cardiomyopathy	0.000135	0.0159	CbGeAlD
Dexamethasone—NR3C1—heart—dilated cardiomyopathy	0.000135	0.0159	CbGeAlD
Dexamethasone—Angioedema—Lisinopril—dilated cardiomyopathy	0.000134	0.00363	CcSEcCtD
Dexamethasone—CYP2C9—heart—dilated cardiomyopathy	0.000134	0.0157	CbGeAlD
Dexamethasone—Malaise—Lisinopril—dilated cardiomyopathy	0.000133	0.00358	CcSEcCtD
Dexamethasone—Vertigo—Lisinopril—dilated cardiomyopathy	0.000132	0.00357	CcSEcCtD
Dexamethasone—Syncope—Lisinopril—dilated cardiomyopathy	0.000132	0.00356	CcSEcCtD
Dexamethasone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000132	0.00356	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000131	0.00353	CcSEcCtD
Dexamethasone—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000129	0.00349	CcSEcCtD
Dexamethasone—Urticaria—Furosemide—dilated cardiomyopathy	0.000127	0.00343	CcSEcCtD
Dexamethasone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000126	0.00341	CcSEcCtD
Dexamethasone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000126	0.00341	CcSEcCtD
Dexamethasone—Myalgia—Lisinopril—dilated cardiomyopathy	0.000125	0.00338	CcSEcCtD
Dexamethasone—Anxiety—Lisinopril—dilated cardiomyopathy	0.000125	0.00337	CcSEcCtD
Dexamethasone—Discomfort—Lisinopril—dilated cardiomyopathy	0.000124	0.00334	CcSEcCtD
Dexamethasone—Oedema—Lisinopril—dilated cardiomyopathy	0.00012	0.00324	CcSEcCtD
Dexamethasone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00012	0.00324	CcSEcCtD
Dexamethasone—Infection—Lisinopril—dilated cardiomyopathy	0.000119	0.00322	CcSEcCtD
Dexamethasone—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.000119	0.014	CbGeAlD
Dexamethasone—Shock—Lisinopril—dilated cardiomyopathy	0.000118	0.00319	CcSEcCtD
Dexamethasone—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000118	0.00317	CcSEcCtD
Dexamethasone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000117	0.00316	CcSEcCtD
Dexamethasone—PTGS2—heart—dilated cardiomyopathy	0.000117	0.0137	CbGeAlD
Dexamethasone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000116	0.00313	CcSEcCtD
Dexamethasone—NR3C1—cardiac atrium—dilated cardiomyopathy	0.000115	0.0136	CbGeAlD
Dexamethasone—Asthenia—Furosemide—dilated cardiomyopathy	0.000115	0.0031	CcSEcCtD
Dexamethasone—Anorexia—Lisinopril—dilated cardiomyopathy	0.000114	0.00309	CcSEcCtD
Dexamethasone—Pruritus—Furosemide—dilated cardiomyopathy	0.000113	0.00306	CcSEcCtD
Dexamethasone—Hypotension—Lisinopril—dilated cardiomyopathy	0.000112	0.00303	CcSEcCtD
Dexamethasone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000109	0.00296	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000109	0.00295	CcSEcCtD
Dexamethasone—Insomnia—Lisinopril—dilated cardiomyopathy	0.000109	0.00293	CcSEcCtD
Dexamethasone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000108	0.00291	CcSEcCtD
Dexamethasone—Dizziness—Furosemide—dilated cardiomyopathy	0.000106	0.00286	CcSEcCtD
Dexamethasone—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000106	0.00285	CcSEcCtD
Dexamethasone—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000104	0.00282	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000104	0.0028	CcSEcCtD
Dexamethasone—Fatigue—Lisinopril—dilated cardiomyopathy	0.000103	0.00279	CcSEcCtD
Dexamethasone—Pain—Lisinopril—dilated cardiomyopathy	0.000103	0.00277	CcSEcCtD
Dexamethasone—Vomiting—Furosemide—dilated cardiomyopathy	0.000102	0.00275	CcSEcCtD
Dexamethasone—Rash—Furosemide—dilated cardiomyopathy	0.000101	0.00272	CcSEcCtD
Dexamethasone—Dermatitis—Furosemide—dilated cardiomyopathy	0.000101	0.00272	CcSEcCtD
Dexamethasone—Headache—Furosemide—dilated cardiomyopathy	0.0001	0.00271	CcSEcCtD
Dexamethasone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	9.89e-05	0.00267	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	9.82e-05	0.00265	CcSEcCtD
Dexamethasone—Urticaria—Lisinopril—dilated cardiomyopathy	9.54e-05	0.00257	CcSEcCtD
Dexamethasone—Nausea—Furosemide—dilated cardiomyopathy	9.5e-05	0.00257	CcSEcCtD
Dexamethasone—Abdominal pain—Lisinopril—dilated cardiomyopathy	9.49e-05	0.00256	CcSEcCtD
Dexamethasone—Body temperature increased—Lisinopril—dilated cardiomyopathy	9.49e-05	0.00256	CcSEcCtD
Dexamethasone—Asthenia—Lisinopril—dilated cardiomyopathy	8.61e-05	0.00233	CcSEcCtD
Dexamethasone—Pruritus—Lisinopril—dilated cardiomyopathy	8.49e-05	0.00229	CcSEcCtD
Dexamethasone—Diarrhoea—Lisinopril—dilated cardiomyopathy	8.21e-05	0.00222	CcSEcCtD
Dexamethasone—Dizziness—Lisinopril—dilated cardiomyopathy	7.94e-05	0.00214	CcSEcCtD
Dexamethasone—Vomiting—Lisinopril—dilated cardiomyopathy	7.63e-05	0.00206	CcSEcCtD
Dexamethasone—Rash—Lisinopril—dilated cardiomyopathy	7.57e-05	0.00204	CcSEcCtD
Dexamethasone—Dermatitis—Lisinopril—dilated cardiomyopathy	7.56e-05	0.00204	CcSEcCtD
Dexamethasone—Headache—Lisinopril—dilated cardiomyopathy	7.52e-05	0.00203	CcSEcCtD
Dexamethasone—ABCB1—heart—dilated cardiomyopathy	7.21e-05	0.0085	CbGeAlD
Dexamethasone—Nausea—Lisinopril—dilated cardiomyopathy	7.13e-05	0.00193	CcSEcCtD
Dexamethasone—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	2.65e-05	0.001	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	2.64e-05	0.000999	CbGpPWpGaD
Dexamethasone—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	2.64e-05	0.000998	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.62e-05	0.00099	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—RAC1—dilated cardiomyopathy	2.6e-05	0.000985	CbGpPWpGaD
Dexamethasone—NOS2—Disease—NPPA—dilated cardiomyopathy	2.59e-05	0.000979	CbGpPWpGaD
Dexamethasone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	2.58e-05	0.000977	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.58e-05	0.000975	CbGpPWpGaD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	2.56e-05	0.000968	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.55e-05	0.000965	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PSEN2—dilated cardiomyopathy	2.5e-05	0.000948	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	2.46e-05	0.000931	CbGpPWpGaD
Dexamethasone—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	2.44e-05	0.000922	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—NPPA—dilated cardiomyopathy	2.42e-05	0.000918	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.42e-05	0.000917	CbGpPWpGaD
Dexamethasone—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	2.37e-05	0.000899	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ANKRD1—dilated cardiomyopathy	2.36e-05	0.000895	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.35e-05	0.000889	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.33e-05	0.00088	CbGpPWpGaD
Dexamethasone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	2.32e-05	0.00088	CbGpPWpGaD
Dexamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	2.28e-05	0.000863	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ANKRD1—dilated cardiomyopathy	2.28e-05	0.000862	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	2.27e-05	0.000859	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	2.27e-05	0.000859	CbGpPWpGaD
Dexamethasone—PGR—Signaling by ERBB4—EGFR—dilated cardiomyopathy	2.24e-05	0.00085	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	2.22e-05	0.000842	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—TAZ—dilated cardiomyopathy	2.22e-05	0.000842	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.21e-05	0.000836	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.18e-05	0.000825	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	2.16e-05	0.000818	CbGpPWpGaD
Dexamethasone—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	2.16e-05	0.000818	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—TAZ—dilated cardiomyopathy	2.14e-05	0.00081	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.08e-05	0.000788	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	2.07e-05	0.000784	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.06e-05	0.000782	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.06e-05	0.000782	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	2.05e-05	0.000777	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.02e-05	0.000766	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—NPPA—dilated cardiomyopathy	2.02e-05	0.000764	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—SDHA—dilated cardiomyopathy	2.01e-05	0.000761	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—RAC1—dilated cardiomyopathy	1.98e-05	0.000749	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.97e-05	0.000746	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	1.95e-05	0.000737	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—SDHA—dilated cardiomyopathy	1.94e-05	0.000733	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	1.93e-05	0.000731	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.92e-05	0.000727	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	1.91e-05	0.000721	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—AGT—dilated cardiomyopathy	1.89e-05	0.000716	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	1.88e-05	0.000712	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.86e-05	0.000704	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—NR3C2—dilated cardiomyopathy	1.86e-05	0.000704	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.85e-05	0.000701	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.84e-05	0.000695	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.83e-05	0.000694	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.8e-05	0.000683	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.8e-05	0.000682	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.78e-05	0.000676	CbGpPWpGaD
Dexamethasone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	1.78e-05	0.000673	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.78e-05	0.000672	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	1.77e-05	0.00067	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	1.76e-05	0.000667	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	1.75e-05	0.000661	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—RAF1—dilated cardiomyopathy	1.73e-05	0.000653	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	1.7e-05	0.000645	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	1.66e-05	0.000627	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	1.66e-05	0.000627	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.63e-05	0.000615	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.62e-05	0.000615	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.61e-05	0.000608	CbGpPWpGaD
Dexamethasone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	1.6e-05	0.000606	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	1.6e-05	0.000606	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.59e-05	0.000601	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.58e-05	0.000599	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	1.58e-05	0.000598	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.54e-05	0.000583	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	1.52e-05	0.000575	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.51e-05	0.00057	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—GPX1—dilated cardiomyopathy	1.5e-05	0.000566	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	1.49e-05	0.000563	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	1.49e-05	0.000562	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	1.48e-05	0.000562	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	1.48e-05	0.00056	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—CD36—dilated cardiomyopathy	1.46e-05	0.000551	CbGpPWpGaD
Dexamethasone—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	1.45e-05	0.000549	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	1.43e-05	0.00054	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.43e-05	0.00054	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	1.4e-05	0.000531	CbGpPWpGaD
Dexamethasone—NR3C1—Adipogenesis—TNF—dilated cardiomyopathy	1.4e-05	0.00053	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	1.4e-05	0.000529	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	1.4e-05	0.000528	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.36e-05	0.000514	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	1.35e-05	0.000511	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	1.34e-05	0.000509	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.32e-05	0.0005	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	1.32e-05	0.000499	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.31e-05	0.000497	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—AGT—dilated cardiomyopathy	1.31e-05	0.000496	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.3e-05	0.000493	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.29e-05	0.00049	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	1.29e-05	0.000489	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	1.29e-05	0.000487	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.28e-05	0.000483	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PSEN2—dilated cardiomyopathy	1.27e-05	0.000481	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	1.26e-05	0.000479	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	1.26e-05	0.000478	CbGpPWpGaD
Dexamethasone—NOS2—Disease—RAC1—dilated cardiomyopathy	1.26e-05	0.000477	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.23e-05	0.000464	CbGpPWpGaD
Dexamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	1.21e-05	0.000458	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	1.21e-05	0.000458	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	1.2e-05	0.000456	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.19e-05	0.000452	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.19e-05	0.000452	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	1.19e-05	0.000451	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.19e-05	0.00045	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.18e-05	0.000447	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—GPX1—dilated cardiomyopathy	1.18e-05	0.000446	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.17e-05	0.000443	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—NPPA—dilated cardiomyopathy	1.17e-05	0.000442	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.15e-05	0.000435	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	1.15e-05	0.000434	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—CD36—dilated cardiomyopathy	1.15e-05	0.000434	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	1.15e-05	0.000434	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CXCL2—dilated cardiomyopathy	1.13e-05	0.000427	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AGTR2—dilated cardiomyopathy	1.13e-05	0.000427	CbGpPWpGaD
Dexamethasone—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.12e-05	0.000424	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.12e-05	0.000424	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—AGT—dilated cardiomyopathy	1.12e-05	0.000423	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	1.09e-05	0.000414	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	1.08e-05	0.000408	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.08e-05	0.000407	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	1.06e-05	0.0004	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.05e-05	0.000399	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CXCR3—dilated cardiomyopathy	1.05e-05	0.000397	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.05e-05	0.000396	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.04e-05	0.000392	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—AGT—dilated cardiomyopathy	1.03e-05	0.000391	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ADRB1—dilated cardiomyopathy	1.02e-05	0.000385	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	9.92e-06	0.000376	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	9.84e-06	0.000372	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	9.76e-06	0.000369	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	9.52e-06	0.000361	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—GPX1—dilated cardiomyopathy	9.02e-06	0.000341	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—EGFR—dilated cardiomyopathy	9e-06	0.000341	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	8.97e-06	0.00034	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	8.9e-06	0.000337	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—CD36—dilated cardiomyopathy	8.78e-06	0.000332	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.68e-06	0.000329	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	8.47e-06	0.00032	CbGpPWpGaD
Dexamethasone—NOS2—Disease—RAF1—dilated cardiomyopathy	8.35e-06	0.000316	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—GPX1—dilated cardiomyopathy	8.25e-06	0.000312	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ADRB2—dilated cardiomyopathy	8.24e-06	0.000312	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NPPA—dilated cardiomyopathy	8.21e-06	0.000311	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.2e-06	0.00031	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	8.19e-06	0.00031	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—GPX1—dilated cardiomyopathy	8.16e-06	0.000309	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—CD36—dilated cardiomyopathy	8.03e-06	0.000304	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.98e-06	0.000302	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PSEN2—dilated cardiomyopathy	7.95e-06	0.000301	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—CD36—dilated cardiomyopathy	7.95e-06	0.000301	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AGT—dilated cardiomyopathy	7.91e-06	0.000299	CbGpPWpGaD
Dexamethasone—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.85e-06	0.000297	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	7.8e-06	0.000295	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—RAF1—dilated cardiomyopathy	7.75e-06	0.000294	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.27e-06	0.000275	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—GPX1—dilated cardiomyopathy	7.24e-06	0.000274	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AGT—dilated cardiomyopathy	7.23e-06	0.000274	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.19e-06	0.000272	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AGT—dilated cardiomyopathy	7.16e-06	0.000271	CbGpPWpGaD
Dexamethasone—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.15e-06	0.000271	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.08e-06	0.000268	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	7.08e-06	0.000268	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—CD36—dilated cardiomyopathy	7.05e-06	0.000267	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	6.9e-06	0.000261	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.67e-06	0.000252	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.49e-06	0.000246	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	6.49e-06	0.000246	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RAC1—dilated cardiomyopathy	6.39e-06	0.000242	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.38e-06	0.000241	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AGT—dilated cardiomyopathy	6.35e-06	0.00024	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.22e-06	0.000235	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AGT—dilated cardiomyopathy	6.11e-06	0.000231	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	6.04e-06	0.000229	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.95e-06	0.000225	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	5.89e-06	0.000223	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	5.87e-06	0.000222	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.85e-06	0.000221	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	5.81e-06	0.00022	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.8e-06	0.000219	CbGpPWpGaD
Dexamethasone—NOS2—Disease—EGFR—dilated cardiomyopathy	5.73e-06	0.000217	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	5.53e-06	0.000209	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—GPX1—dilated cardiomyopathy	5.46e-06	0.000207	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.43e-06	0.000205	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—CD36—dilated cardiomyopathy	5.32e-06	0.000201	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.32e-06	0.000201	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	5.3e-06	0.000201	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.29e-06	0.0002	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—GPX1—dilated cardiomyopathy	5.26e-06	0.000199	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.22e-06	0.000198	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—CD36—dilated cardiomyopathy	5.12e-06	0.000194	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AGT—dilated cardiomyopathy	4.79e-06	0.000181	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	4.79e-06	0.000181	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.76e-06	0.00018	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	4.74e-06	0.00018	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—CD36—dilated cardiomyopathy	4.66e-06	0.000176	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	4.62e-06	0.000175	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AGT—dilated cardiomyopathy	4.61e-06	0.000175	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	4.35e-06	0.000165	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—RAF1—dilated cardiomyopathy	4.24e-06	0.00016	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	4.23e-06	0.00016	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AGT—dilated cardiomyopathy	4.2e-06	0.000159	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	4.16e-06	0.000157	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—RAC1—dilated cardiomyopathy	4e-06	0.000151	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	3.81e-06	0.000144	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	3.65e-06	0.000138	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—CD36—dilated cardiomyopathy	3.55e-06	0.000135	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	3.51e-06	0.000133	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	3.44e-06	0.00013	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	3.43e-06	0.00013	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	3.42e-06	0.000129	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.36e-06	0.000127	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	3.35e-06	0.000127	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	3.34e-06	0.000126	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	3.24e-06	0.000123	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AGT—dilated cardiomyopathy	3.2e-06	0.000121	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	3.15e-06	0.000119	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	3.08e-06	0.000116	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	3.01e-06	0.000114	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	3.01e-06	0.000114	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	2.97e-06	0.000112	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—EGFR—dilated cardiomyopathy	2.91e-06	0.00011	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	2.89e-06	0.000109	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	2.84e-06	0.000108	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—RAF1—dilated cardiomyopathy	2.65e-06	0.0001	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	2.65e-06	0.0001	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	2.6e-06	9.86e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.59e-06	9.79e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	2.58e-06	9.77e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2.52e-06	9.54e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.44e-06	9.23e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	2.42e-06	9.15e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.37e-06	8.99e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	2.35e-06	8.91e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	2.32e-06	8.8e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.27e-06	8.59e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.14e-06	8.09e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.12e-06	8.02e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—EGFR—dilated cardiomyopathy	1.82e-06	6.88e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.59e-06	6.03e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.55e-06	5.88e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.4e-06	5.29e-05	CbGpPWpGaD
